Join us at Asembia's AXS24 Summit

April 28 – May 2, 2024 | Booth #1309

Proud Sponsor of Asembia’s AXS24 Summit

Biologics by McKesson is excited to sponsor Asembia’s AXS24 Summit on April 28 – May 2, 2024, at the Wynn & Encore hotel of Las Vegas. The AXS24 Summit will bring together thousands of decision makers from the nation’s leading pharmacy and pharmaceutical industry as they celebrate 20 years of Leadership.

Join us during Asembia for insightful discussions on how Biologics’ specialty pharmacy can be the right commercialization partner for your therapy. This will be one of the most elite B2B conferences in the pharmaceutical industry and we hope to see you there.

Planning on attending AXS24 Summit?

Ela Lourido

VP/GM, Specialty Pharmacy Solutions

Ela Lourido LinkedIn

Ben Matherne

Sr. Director, Strategic Accounts

Ben Matherne LinkedIn

Ryan Hampton

Sr. Director, Strategic Initiatives and Implementations

Ryan Hampton LinkedIn

George Paschal

Sr. Director, Business Development

George Paschal LinkedIn

Michele Bargholz

Director, Client Relationship

Michele Bargholz LinkedIn

Daniel Weaver

Director, Clinical Strategy & Innovation

Daniel Weaver LinkedIn

Chris Alfaro

Sr. Manager, Strategic Accounts

Charles Shaw LinkedIn

James Anderson

Sr. Program Manager, Account Manager

Charles Shaw LinkedIn

Haleigh Broglin

Sr. Manager, Business Development

Haleigh Broglin LinkedIn

Christian Hawkins

Sr. Manager, Client Relationship

Charles Shaw LinkedIn

Carly Richardson

Sr. Manager, Client Relationship

Charles Shaw LinkedIn

Charles Shaw

Sr. Manager, Strategic Accounts

Charles Shaw LinkedIn

Planning on attending AXS24 Summit?

Ela Lourido

VP/GM, Specialty Pharmacy Solutions

Ben Matherne

Sr. Director, Strategic Accounts

Ryan Hampton

Directory, Customer Strategy & Implementations

George Paschal Biologics Director, Business Development

George Pachal

Sr. Director, Business Development, Biologics by McKesson

Michele Bargholz Biologics Director, Client Relationship

Michele Bargholz

Director, Client Relationship

Daniel Weaver, Biologics Director, Clinical Strategy & Innovation

Daniel Weaver

Director, Clinical Innovation & Strategy

Chris Alfaro

Sr. Manager, Strategic Accounts

James Anderson

Sr. Program Manager, Account Manager

Haleigh Broglin Biologics Sr. Manager, Business Development

Haleigh Broglin

Sr. Manager, Business Development

Christian Hawkins

Sr. Manager, Client Relationship

Carly Richardson

Sr. Manager, Client Relationship

Charles Shaw, Biologics Sr. Manager, Strategic Accounts

Charles Shaw

Sr. Manager, Strategic Accounts

Hear from Our Experts at Asembia

Innovative payment models for CGT that address the payers, employers and patient concerns of cost.
April 30, 2024 at 2PM PT

  • Joe DePinto, Head of Cell, Gene and Advance Therapies, McKesson
  • Eddie Albers, Managing Director – US Life Sciences Practice
  • Emad Samad, President, Octaviant Financial


What’s around the corner? Navigating the Future Regulatory Landscape of Specialty Pharmacy.
May 1, 2024 at 1PM PT

  • Ann Fritsche, Managing Senior Counsel, Biologics
  • Leah Tinney, Senior Counsel, McKesson
  • Nick Meza, Partner, Quarles